Is SINT or XAIR more profitable?

Beyond Air has a net margin of -435.71% compared to Sintx Technologies' net margin of -848.20%. Sintx Technologies' return on equity of -354.44% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets Sintx Technologies -848.20% -354.44% -115.37% Beyond Air -435.71% -440.26% -98.50%

Does the media refer more to SINT or XAIR?

In the previous week, Beyond Air had 4 more articles in the media than Sintx Technologies. MarketBeat recorded 8 mentions for Beyond Air and 4 mentions for Sintx Technologies. Sintx Technologies' average media sentiment score of 0.77 beat Beyond Air's score of 0.46 indicating that Sintx Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sintx Technologies 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Beyond Air 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend NVNO or XAIR?

Beyond Air has a consensus target price of $105.00, indicating a potential upside of 4,694.52%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts clearly believe Beyond Air is more favorable than enVVeno Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33 Beyond Air 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Do analysts recommend XAIR or INBS?

Beyond Air currently has a consensus price target of $105.00, suggesting a potential upside of 4,694.52%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts clearly believe Beyond Air is more favorable than Intelligent Bio Solutions. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beyond Air 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Intelligent Bio Solutions 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts rate SONX or XAIR?

Beyond Air has a consensus target price of $105.00, indicating a potential upside of 4,694.52%. Given Beyond Air's stronger consensus rating and higher probable upside, analysts clearly believe Beyond Air is more favorable than Sonendo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Beyond Air 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has preferable valuation and earnings, SONX or XAIR?

Beyond Air has lower revenue, but higher earnings than Sonendo. Beyond Air is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sonendo $44.40M 0.14 -$60.92M -$71.12 N/A Beyond Air $7.68M 0.27 -$33.25M -$68.40 N/A

Is SONX or XAIR more profitable?

Sonendo has a net margin of -92.74% compared to Beyond Air's net margin of -435.71%. Sonendo's return on equity of -184.01% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets Sonendo -92.74% -184.01% -68.60% Beyond Air -435.71% -440.26% -98.50%

Beyond Air (XAIR) Competitors

$2.19 -0.12 (-5.19%)

Closing price 10/13/2026 04:00 PM Eastern

Extended Trading

$2.10 -0.09 (-4.11%)

As of 09:14 AM Eastern

Compare

XAIR vs. SINT, NDRA, NVNO, INBS, and SONX

Should you buy Beyond Air stock or one of its competitors? Beyond Air's main competitors and comparable companies include Sintx Technologies (SINT), ENDRA Life Sciences (NDRA), enVVeno Medical (NVNO), Intelligent Bio Solutions (INBS), and Sonendo (SONX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Beyond Air compare to Sintx Technologies?

Sintx Technologies (NASDAQ:SINT) and Beyond Air (NASDAQ:XAIR) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

Beyond Air has a net margin of -435.71% compared to Sintx Technologies' net margin of -848.20%. Sintx Technologies' return on equity of -354.44% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-848.20%	-354.44%	-115.37%
Beyond Air	-435.71%	-440.26%	-98.50%

Sintx Technologies has higher earnings, but lower revenue than Beyond Air. Sintx Technologies is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$1.02M	8.77	-$10.36M	-$4.91	N/A
Beyond Air	$7.68M	0.27	-$33.25M	-$68.40	N/A

Sintx Technologies presently has a consensus price target of $9.50, suggesting a potential upside of 358.94%. Beyond Air has a consensus price target of $105.00, suggesting a potential upside of 4,694.52%. Given Beyond Air's higher possible upside, analysts clearly believe Beyond Air is more favorable than Sintx Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Beyond Air had 4 more articles in the media than Sintx Technologies. MarketBeat recorded 8 mentions for Beyond Air and 4 mentions for Sintx Technologies. Sintx Technologies' average media sentiment score of 0.77 beat Beyond Air's score of 0.46 indicating that Sintx Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sintx Technologies	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Beyond Air	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by insiders. Comparatively, 10.0% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Beyond Air beats Sintx Technologies on 7 of the 12 factors compared between the two stocks.

How does Beyond Air compare to ENDRA Life Sciences?

ENDRA Life Sciences (NASDAQ:NDRA) and Beyond Air (NASDAQ:XAIR) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation.

1.2% of ENDRA Life Sciences shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 10.0% of ENDRA Life Sciences shares are owned by insiders. Comparatively, 10.0% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

ENDRA Life Sciences has a beta of -0.09, meaning that its stock price is 109% less volatile than the broader market. Comparatively, Beyond Air has a beta of 0.21, meaning that its stock price is 79% less volatile than the broader market.

ENDRA Life Sciences has higher earnings, but lower revenue than Beyond Air. ENDRA Life Sciences is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ENDRA Life Sciences	N/A	N/A	-$7.03M	-$6.38	N/A
Beyond Air	$7.68M	0.27	-$33.25M	-$68.40	N/A

In the previous week, Beyond Air had 7 more articles in the media than ENDRA Life Sciences. MarketBeat recorded 8 mentions for Beyond Air and 1 mentions for ENDRA Life Sciences. ENDRA Life Sciences' average media sentiment score of 1.79 beat Beyond Air's score of 0.46 indicating that ENDRA Life Sciences is being referred to more favorably in the media.

Company	Overall Sentiment
ENDRA Life Sciences	Very Positive
Beyond Air	Neutral

ENDRA Life Sciences has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. ENDRA Life Sciences' return on equity of -246.34% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ENDRA Life Sciences	N/A	-246.34%	-150.81%
Beyond Air	-435.71%	-440.26%	-98.50%

ENDRA Life Sciences presently has a consensus price target of $25.00, indicating a potential upside of 396.03%. Beyond Air has a consensus price target of $105.00, indicating a potential upside of 4,694.52%. Given Beyond Air's stronger consensus rating and higher probable upside, analysts plainly believe Beyond Air is more favorable than ENDRA Life Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ENDRA Life Sciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Beyond Air beats ENDRA Life Sciences on 8 of the 14 factors compared between the two stocks.

How does Beyond Air compare to enVVeno Medical?

enVVeno Medical (NASDAQ:NVNO) and Beyond Air (NASDAQ:XAIR) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.

enVVeno Medical has higher earnings, but lower revenue than Beyond Air. enVVeno Medical is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
enVVeno Medical	N/A	N/A	-$19.47M	-$19.33	N/A
Beyond Air	$7.68M	0.27	-$33.25M	-$68.40	N/A

In the previous week, Beyond Air had 7 more articles in the media than enVVeno Medical. MarketBeat recorded 8 mentions for Beyond Air and 1 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 1.79 beat Beyond Air's score of 0.46 indicating that enVVeno Medical is being referred to more favorably in the media.

Company	Overall Sentiment
enVVeno Medical	Very Positive
Beyond Air	Neutral

enVVeno Medical has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. enVVeno Medical's return on equity of -62.28% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
enVVeno Medical	N/A	-62.28%	-56.83%
Beyond Air	-435.71%	-440.26%	-98.50%

enVVeno Medical has a beta of 1.29, meaning that its stock price is 29% more volatile than the broader market. Comparatively, Beyond Air has a beta of 0.21, meaning that its stock price is 79% less volatile than the broader market.

Beyond Air has a consensus target price of $105.00, indicating a potential upside of 4,694.52%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts clearly believe Beyond Air is more favorable than enVVeno Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

34.7% of enVVeno Medical shares are held by institutional investors. Comparatively, 31.5% of Beyond Air shares are held by institutional investors. 15.0% of enVVeno Medical shares are held by company insiders. Comparatively, 10.0% of Beyond Air shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

enVVeno Medical beats Beyond Air on 10 of the 15 factors compared between the two stocks.

How does Beyond Air compare to Intelligent Bio Solutions?

Beyond Air (NASDAQ:XAIR) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation.

Beyond Air currently has a consensus price target of $105.00, suggesting a potential upside of 4,694.52%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts clearly believe Beyond Air is more favorable than Intelligent Bio Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Intelligent Bio Solutions has lower revenue, but higher earnings than Beyond Air. Intelligent Bio Solutions is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$7.68M	0.27	-$33.25M	-$68.40	N/A
Intelligent Bio Solutions	$4.22M	1.16	-$12.43M	-$9.02	N/A

In the previous week, Beyond Air had 6 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 8 mentions for Beyond Air and 2 mentions for Intelligent Bio Solutions. Intelligent Bio Solutions' average media sentiment score of 1.45 beat Beyond Air's score of 0.46 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.

Company	Overall Sentiment
Beyond Air	Neutral
Intelligent Bio Solutions	Positive

31.5% of Beyond Air shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 10.0% of Beyond Air shares are owned by company insiders. Comparatively, 1.3% of Intelligent Bio Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Intelligent Bio Solutions has a net margin of -294.88% compared to Beyond Air's net margin of -435.71%. Intelligent Bio Solutions' return on equity of -175.35% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-435.71%	-440.26%	-98.50%
Intelligent Bio Solutions	-294.88%	-175.35%	-91.25%

Beyond Air has a beta of 0.21, meaning that its share price is 79% less volatile than the broader market. Comparatively, Intelligent Bio Solutions has a beta of 4.31, meaning that its share price is 331% more volatile than the broader market.

Summary

Intelligent Bio Solutions beats Beyond Air on 9 of the 15 factors compared between the two stocks.

How does Beyond Air compare to Sonendo?

Sonendo (NYSE:SONX) and Beyond Air (NASDAQ:XAIR) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations.

Beyond Air has a consensus target price of $105.00, indicating a potential upside of 4,694.52%. Given Beyond Air's stronger consensus rating and higher probable upside, analysts clearly believe Beyond Air is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Beyond Air had 8 more articles in the media than Sonendo. MarketBeat recorded 8 mentions for Beyond Air and 0 mentions for Sonendo. Beyond Air's average media sentiment score of 0.46 beat Sonendo's score of 0.00 indicating that Beyond Air is being referred to more favorably in the news media.

Company	Overall Sentiment
Sonendo	Neutral
Beyond Air	Neutral

28.7% of Sonendo shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 7.9% of Sonendo shares are owned by insiders. Comparatively, 10.0% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Beyond Air has lower revenue, but higher earnings than Sonendo. Beyond Air is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.14	-$60.92M	-$71.12	N/A
Beyond Air	$7.68M	0.27	-$33.25M	-$68.40	N/A

Sonendo has a net margin of -92.74% compared to Beyond Air's net margin of -435.71%. Sonendo's return on equity of -184.01% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Beyond Air	-435.71%	-440.26%	-98.50%

Sonendo has a beta of 1.86, suggesting that its stock price is 86% more volatile than the broader market. Comparatively, Beyond Air has a beta of 0.21, suggesting that its stock price is 79% less volatile than the broader market.

Summary

Beyond Air beats Sonendo on 10 of the 15 factors compared between the two stocks.

Get Beyond Air News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XAIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XAIR vs. The Competition

Export

Metric	Beyond Air	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.21M	$5.58B	$7.26B	$13.21B
Dividend Yield	N/A	1.75%	2.52%	22.89%
P/E Ratio	N/A	20.86	204.95	19.81
Price / Sales	0.27	67.21	562.00	81.34
Price / Cash	N/A	32.25	77.16	53.04
Price / Book	0.23	5.86	10.75	6.03
Net Income	-$33.25M	$146.14M	$3.50B	$380.34M
7 Day Performance	-13.78%	-0.98%	-2.90%	-2.34%
1 Month Performance	-30.25%	-3.62%	-7.37%	-5.31%
1 Year Performance	-95.94%	1.42%	2.97%	-2.94%

Beyond Air Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XAIR Beyond Air	3.2997 of 5 stars	$2.19 -5.2%	$105.00 +4,694.5%	-95.8%	$2.21M	$7.68M	N/A	54	News Coverage
SINT Sintx Technologies	2.6102 of 5 stars	$2.13 -2.2%	$9.50 +345.8%	-48.9%	$9.21M	$1.02M	N/A	32
NDRA ENDRA Life Sciences	3.235 of 5 stars	$6.10 +1.0%	$25.00 +309.8%	-37.9%	$9.11M	N/A	N/A	11
NVNO enVVeno Medical	1.5401 of 5 stars	$8.05 -1.9%	N/A	-69.3%	$5.55M	N/A	N/A	33	Gap Down
INBS Intelligent Bio Solutions	1.4004 of 5 stars	$1.58 -0.3%	N/A	-86.2%	$5.22M	$4.22M	N/A	10	Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XAIR) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Beyond Air (XAIR) Competitors

XAIR vs. SINT, NDRA, NVNO, INBS, and SONX

How does Beyond Air compare to Sintx Technologies?

Summary

How does Beyond Air compare to ENDRA Life Sciences?

Summary

How does Beyond Air compare to enVVeno Medical?

Summary

How does Beyond Air compare to Intelligent Bio Solutions?

Summary

How does Beyond Air compare to Sonendo?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Beyond Air (XAIR) Competitors

XAIR vs. SINT, NDRA, NVNO, INBS, and SONX

How does Beyond Air compare to Sintx Technologies?

Is SINT or XAIR more profitable?

Which has better valuation & earnings, SINT or XAIR?

Do analysts rate SINT or XAIR?

Does the media refer more to SINT or XAIR?

Do institutionals and insiders hold more shares of SINT or XAIR?

Summary

How does Beyond Air compare to ENDRA Life Sciences?

Do institutionals & insiders believe in NDRA or XAIR?

Which has more risk & volatility, NDRA or XAIR?

Which has stronger valuation & earnings, NDRA or XAIR?

Does the media prefer NDRA or XAIR?

Is NDRA or XAIR more profitable?

Do analysts prefer NDRA or XAIR?

Summary

How does Beyond Air compare to enVVeno Medical?

Which has higher earnings & valuation, NVNO or XAIR?

Does the media favor NVNO or XAIR?

Is NVNO or XAIR more profitable?

Which has more volatility and risk, NVNO or XAIR?

Do analysts recommend NVNO or XAIR?

Do insiders & institutionals have more ownership in NVNO or XAIR?

Summary

How does Beyond Air compare to Intelligent Bio Solutions?

Do analysts recommend XAIR or INBS?

Which has preferable earnings & valuation, XAIR or INBS?

Does the media favor XAIR or INBS?

Do institutionals & insiders hold more shares of XAIR or INBS?

Is XAIR or INBS more profitable?

Which has more volatility & risk, XAIR or INBS?

Summary

How does Beyond Air compare to Sonendo?

Do analysts rate SONX or XAIR?

Does the media prefer SONX or XAIR?

Do insiders and institutionals have more ownership in SONX or XAIR?

Which has preferable valuation and earnings, SONX or XAIR?

Is SONX or XAIR more profitable?

Which has more risk and volatility, SONX or XAIR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools